CGB3: A Promising Cannabigerol Compound with Therapeutic Benefits

Target Name: CGB3

NCBI ID: G1082

CGB3

CGB3: A Promising Cannabigerol Compound with Therapeutic Benefits

CGB3 (Cannabigerol) is a non-psychoactive compound found in the cannabis plant that has been shown to have potential therapeutic benefits. CGB3 has been shown to have anti-inflammatory properties, which can be useful in the treatment of a variety of conditions including arthritis, autoimmune diseases, and even certain types of cancer.

One of the reasons for CGB3's potential therapeutic benefits is its ability to interact with the endocannabinoid system (ECS), which is a complex cell-signaling system found in all mammals. The ECS is responsible for maintaining the body's balance of pain, inflammation, and other physiological processes.

In addition to its potential therapeutic benefits, CGB3 has also been shown to have potential as a drug target. The DEA (Dopamine and Enkeji) receptor is a dopamine receptor that is involved in the sensation of pleasure and reward. CGB3 has been shown to interact with the DEA receptor, which can lead to potential therapeutic benefits in the treatment of certain mental health conditions such as depression and anxiety.

Another potential therapeutic benefit of CGB3 is its ability to modulate the activity of the TRPV1 (Touch-sensitive protein) receptor, which is responsible for mediating pain and inflammation. By modulating the activity of TRPV1, CGB3 may have potential therapeutic benefits in the treatment of chronic pain conditions.

In addition to its potential therapeutic benefits, CGB3 has also been shown to have potential as a biomarker. The use of CGB3 as a biomarker may have potential implications for the development of non-invasive diagnostic tests for certain medical conditions.

Overall, CGB3 is a promising compound with potential therapeutic benefits. Further research is needed to fully understand its effects and potential as a drug target and biomarker.

Protein Name: Chorionic Gonadotropin Subunit Beta 3

Functions: Beta subunit of the human chorionic gonadotropin (hCG). hCG is a complex glycoprotein composed of two glycosylated subunits alpha and beta which are non-covalently associated. The alpha subunit is identical to those in the pituitary gonadotropin hormones (LH, FSH and TSH). The beta subunits are distinct in each of the hormones and confer receptor and biological specificity. Has an essential role in pregnancy and maternal adaptation. Stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy

The "CGB3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CGB3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets